Among these are downstream and upstream combined inhibition of BRN2 by small molecules targeting its effectors EZH2 or its transcriptional regulator NFATc2, respectively, as observed in NFAT2+ EZH2+ melanoma cell lines [40,82]. This evidence concerns the gene POU3F2 and melanoma.